Study #2019-0330
A Survey of High Risk Patient and Caregiver Attitudes and Beliefs Regarding the Prescription of Intranasal Naloxone Spray for Opioid Overdose
MD Anderson Study Status
Not Accepting
Treatment Agent
Description
This trial studies the attitudes and beliefs of high risk patients and caregivers regarding the prescription of intranasal naloxone spray for opioid overdose. Knowledge regarding high risk patients' and caregivers' beliefs and attitudes regarding co-prescription of naloxone spray with opioids may help to identify barriers to prescribing and helping tailor the education to better meet the needs of patients and caregivers.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Caregiver;Patient
Study phase:
Physician name:
Jaya Amaram-Davila
Department:
Palliative Care & Rehabilitation Medicine
For general questions about clinical trials:
1-866-407-7176
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.